Testing a ketogenic diet or ketone drink in people with glioma that came back
Official title: GLAD-KE GLioma Biomarker and Safety Assessment During Dietary Ketone Elevation Subtitle: A Surgical Biomarker Discovery Study of Ketogenic Therapy in Recurrent Glioma
Status: Not yet recruiting. It has not opened yet. Ask your care team to watch for it if it looks like a fit.
The trial team last updated this record on .
The short version
This study looks at whether a high fat diet or a ketone supplement is safe and doable before brain surgery.
Read our full plain-language summary
What the trial team says
This study is being done to see if a Ketogenic Diet (KD) or short-term Ketone supplement (KS) is feasible and safe for patients with recurrent Glioma who are undergoing a clinically indicated surgery.
Key facts
- Registry number
- NCT07852975
- Stage of testing
- Not applicable
- Conditions studied
- Recurrent Glioma (Glioblastoma Multiforme)
Where it is running
This trial lists 1 site.
-
Maryland
- Oncology- Broadway (Baltimore)
How to use this
Talk to your care team first. They know your history and can tell you whether this trial is worth your time.
Joining a trial is always your choice. A trial is a test, not a proven treatment. Being in one is not a promise that it will help you.
This page is built from the trial's listing on ClinicalTrials.gov, a service of the U.S. National Library of Medicine. That listing is the authority, and it may have changed since we last read it. We do not run this trial and we cannot enroll you in it.